ClinicalTrials.govpublic full text
A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease
autoimmune diseases, systemic lupus erythematosus, belantamab (gsk2857914), autoimmune disease, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 849200
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.